The introduction of human monoclonal anti-D for therapeutic use.
New South Wales Red Cross Blood Transfusion Service, Sydney, Australia.
A
A
Fletcher
A
A
Thomson
D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D000918:Antibody Specificity; D002986:Clinical Trials as Topic; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D004992:Ethics, Medical; D005260:Female; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D007116:Immunization, Passive / Q000592:standards; D007140:Immunoglobulin Fab Fragments / Q000235:genetics / Q000276:immunology; D007074:Immunoglobulin G / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D007231:Infant, Newborn; D007518:Isoantibodies / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D010587:Phagocytosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology / Q000628:therapy*; D015202:Protein Engineering; D011961:Receptors, Fc / Q000276:immunology; D012203:Rh Isoimmunization / Q000628:therapy*; D012204:Rh-Hr Blood-Group System / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007518:Isoantibodies; D011961:Receptors, Fc; D012204:Rh-Hr Blood-Group System; C026410:Rho(D) antigen